Fortis Healthcare Ltd.Fortis Healthcare Ltd.

Investor PresentationInvestor PresentationQ3 Q3 –– FY 2010FY 2010

Safe HarborSafe Harbor

Except for the historical information contained herein, statements in this presentation and the subsequent discussions, which include words or phrases such as

“will”, “aim”, “will likely result”, “would”, “believe”, “may”, “expect”, “will continue”, “anticipate”, “estimate”, “intend”, “plan”, “contemplate”, “seek

to”, “future”, “objective”, “goal”, “likely”, “project”, “should”, “potential”, “will pursue” and similar expressions or variations of such expressions may

constitute "forward-looking statements". These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual

results to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include, but are not limited to our ability to

successfully implement our strategy, our growth and expansion plans, obtain regulatory approvals, our provisioning policies, technological changes, investment

and business income, cash flow projections, our exposure to market risks as well as other risks. Fortis does not undertake any obligation to update forward-

looking statements to reflect events or circumstances after the date thereof.

“Fortis Healthcare Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a rights issue of its equity shares

with warrants and to file a Draft Letter of Offer with SEBI.” This presentation is not and should not be construed as an offer for sale within the United States of

any rights, warrants, equity shares or any other security of Fortis Healthcare Limited or as a solicitation of an offer to buy any of such rights, warrants, equity

shares or other securities. Securities of Fortis Healthcare Limited, including any offering of its rights, warrants, equity shares or any other security, may not be

offered, sold, resold or otherwise transferred within the United States absent registration under U.S securities laws or unless exempt from registration under such

laws. The offering of the securities of Fortis Healthcare Limited described in this advertisement has not been and will not be registered under U.S securities laws,

and accordingly, any offer or sale of these securities may be made only in a transaction exempt from registration.

2

AgendaAgenda

�Hospital Performances

�Q&A

3

�Highlights of the Quarter

�Operating Parameters

Highlights of the quarterHighlights of the quarter

� The acquisition of 10 Wockhardt’s hospitals (including 2 hospitals in project stages), completed on

17th December.

� Ties up for management of 175 bedded MK Hospital – Bhiwani, Haryana

� 13 hospitals in the network recorded all time high revenues

� Malar and Amritsar Hospital grew sequentially over the 8th quarter

� Fortis Escorts Delhi grew sequentially over the 6th quarter

� Noida, Vasant Kunj and Jaipur grew sequentially over the 4th quarter

� Launched a new clinic at Fortis La Femme dedicated towards foetal medicine

� Launched Cancer care clinic named “Cancure” at Vashi, in association with Dr. Suresh Advani

� Kicked-off cardiac surgery programme at Clinique Darne and also launched a comprehensive

mother and child care programme

� Construction completed for Oncology Block at Noida. Operations commence from ensuing quarter

4

Operating HighlightsOperating Highlights

� Financial Information:

� Network Operating Revenues: Q3 – Rs. 299 Cr. (+59%); 9M – Rs. 808 Cr. (+51%)

� Consolidated Operating Revenue: Q3 – Rs. 232 Cr. (+44%); 9M – Rs. 608 Cr. (+33%)

� Consolidated Operating EBITDA: Q3 – Rs. 35.6 Cr. (+43%); 9M – Rs. 93.5 Cr. (+56%)

� Net Profit for the quarter stood at Rs. 21.7 Cr., +330% over corresponding period

� EPS for the quarter grows from Re. 0.22 / share to Re. 0.88 / share

� Fortis Escorts Delhi achieved highest ever revenues of Rs. 70 Cr. for a quarter

� Fortis Escorts Delhi (+28%), Noida (+30%), Malar (+112%), Faridabad (+35%), Vasant Kunj (+44%), Jaipur

(+85%) and La Femme (+27%) also grew smartly

� Revenues from Cardiac, Ortho, Neuro, Renal Sciences, Oncology and Gastroenterology grew by 36%,

19%, 93%, 28%, 44% & 50% respectively

� Observed 98% increase in Neuro Surgery procedures over the corresponding quarter lead by Noida, Faridabad,

Jaipur, Vasant Kunj & Malar

5

Update on Wockhardt acquisitionUpdate on Wockhardt acquisition

� Business transfer completed effective w.e.f

17th Dec 2009

� Transition of ~3,200 employees and

consultants to Fortis

� IT platform integration completed

� Senior management team strengthened in

the areas of finance and projects

� 414 bedded Kolkata project and Mulund

hospital’s expansion work started

6

Wockhardt Hospital, Mulund, Mumbai

Wockhardt Hospital, Kolkata*

Brand TransitionBrand Transition

7

Combined Business Presence Combined Business Presence –– Pan IndiaPan India

8

Fortis City Centre (2006)

Fortis Mohali (2001)

La Femme (2005)

Jessa Ram (2003)

Fortis Noida (2004)

Vasant Kunj (2006)

Kalyani, Gurgaon (2006)

Fortis Escorts Jaipur

(2006)

Fortis Modi Hospital, Kota (2006)

HHPL (Mumbai) (2007)

Escorts-Raipur (2006)

Fortis Malar (Chennai) 2008

Fortis, RM Hospital, Bengaluru (2009)

Escorts-Delhi (2006)

Arneja Hospital,

Nagpur(2006)

Birla Institute MRC, Gwalior (2006)

Goyal Hospital,

Jodhpur (2006)

Escorts, Amritsar (2006)

Escorts, Faridabad

Ravindera Cath Lab, Hisar

Sadbhavna Medical &

Heart Institute, Patiala (2006)

Kamayani, Agra (2006)

Saraswati Heart Care, Allahabad (2006)

ISIC, Vasant Kunj (2006)

Yashoda Hospital, Ghaziabad (2006)

SL Raheja (Mumbai) (2010)

Fortis Shalimar Bagh (2010)

Fortis Gurgaon

Fortis Wockhardt Total

Particulars No. Capacity No. Capacity No. Capacity

Greenfield 3 970 3 970

Brownfield 6 1,147 8 1,368 14 2,515

Managed 8 1,318 8 1,318

HCC’s/SC’s 13 72 13 72

Projects 5 1,200 2 534 7 1,734

Total 35 4,707 10 1,902 45 6,609

GNRC, Guwahati (2009)

International Projects

• Escorts-Amiri Diagnostic Heart Center, Afghanistan (FY2006)

• Mauritius (FY2009)

Fortis MK Hospital,

Bhiwani (2010)

Wockhardt – Sarat Bose Road, Kolkata (2009)

Wockhardt – Rashbehari Avenue, Kolkata (2009)

Wockhardt Hospital, (Anandpur) Kolkata (2009)

Wockhardt, Kalyan (2009)

Wockhardt, Mulund (2009)

Wockhardt, BG Road, Bengaluru (2009)

Wockhardt, CH Road, Bengaluru (2009)

Wockhardt, Cunningham Road, Bengaluru (2009)Wockhardt, Yashwant Pura, Bengaluru (2009)

Wockhardt, Nagarbhavi, Bengaluru (2009)

505 463

6761045

Knee Replacements THR & Others

1,288 1,529 1,560 2,095

3,774 4,988

612

936

CTVS & Pediatrics PTCA CAG Others

Dialysis

7,641

15,938

No. of ProceduresNo. of Procedures

9

+32%

Q3 FY 09 Q3 FY 10

+28%

Neuro

353

699 +98%

+109%

Cardiac Ortho

10

��Performance HighlightsPerformance Highlights

Consolidated: FHL and Subsidiaries

Network: FHL, Subsidiaries, Associates and O&M Hospitals

0

50

100

150

200

250

300

Consolidated Network

161

189

232

299 Q3FY09 Q3FY10

11

� Q3 FY 10 – Consolidated

� Operating Revenue - Rs. 232.5 Cr ���� 44%

� Operating EBITDA - Rs. 35.6 Cr ���� 43%

� Net Profit - Rs. 21.7 Cr ���� 330%

� Q3FY10 - Network Revenue - Rs. 299.1 Cr. ���� 59%

� 9M FY10 – Consolidated

� Operating Revenue - Rs. 608.4 Cr. ���� 33%

� Operating EBITDA - Rs. 93.5 Cr. ���� 56%

� Net Profit - Rs. 42.3 Cr. ���� 330%

� 9M FY10 - Network Revenue - Rs. 808.2 Cr. ���� 49%

Snapshot Snapshot –– Financial PerformanceFinancial Performance

Rs. in Cr.

Statutory Q3FY09 Q3FY10

Occupancy 70% 74%

ARPOB (Annualized - Rs. Lakhs) 75 86

ALOS (Days) 3.9 3.7

+44%

+59%

Operating Revenues

Operating Revenue and PATOperating Revenue and PAT

12

161.1

172.6

185.4190.5

232.5

13.0

21.7

7.6

6.2

5.1

0.0

50.0

100.0

150.0

200.0

250.0

Q3FY09 Q4FY09 Q1FY10 Q2FY10 Q3FY10

0.0

5.0

10.0

15.0

20.0

25.0

Operating Revenues PAT

Rs. in Cr.

Revenues

44%

PAT

330%

*PAT above is excluding exceptional items of gain of Rs. 6. 2 Cr. in Q2FY09 and our share of loss of Rs. 1.4 Cr in Malar hospital in Q4FY09

Consecutive positive returns

Summary Summary –– Consolidated Profit and Loss Consolidated Profit and Loss –– Q3 FY10Q3 FY10

Particulars Q3 FY10

(Rs. Cr.) %

Q3 FY09

(Rs. Cr.) %

Q-o-Q

Growth

Operating Revenue 232.5 100.0% 161.1 100.0% 44.3%

Other Income # 8.7 3.7% 5.8 3.6% 50.8%

Total Income 241.2 166.8 44.6%

Direct Costs 64.3 27.7% 46.3 28.7% 39.0%

Employee Costs 48.2 20.7% 39.1 24.3% 23.3%

Other Costs 84.4 36.3% 50.8 31.6% 66.0%

EBITDA 44.3 19.0% 30.6 19.0% 44.5%

Finance Costs 6.9 3.0% 11.2 7.0% -38.8%

Depreciation & Amortization 13.8 5.9% 11.9 7.4% 16.2%

PAT 21.7 9.4% 5.1 3.1% 329.6%

EPS for the quarter (Rs.) 0.88 0.22

13

#Other income includes interest income and miscellaneous income

Summary Summary –– Consolidated Profit and Loss Consolidated Profit and Loss –– 9MFY109MFY10

14

Particulars 9MFY10

(Rs. Cr.)(%)

9MFY09

(Rs. Cr.)(%) Growth (%)

Operating Revenue 608.4 100.0% 457.9 100.0% 32.9%

Other Income # 15.4 2.5% 23.9 5.2% -35.7%

Total Income 623.8 481.9 29.5%

Direct Costs 171.9 28.2% 134.6 29.4% 27.7%

Employee Costs 132.7 21.8% 112.1 24.5% 18.4%

Other Costs 210.3 34.6% 151.6 33.1% 38.8%

EBITDA 108.9 17.9% 83.7 18.3% 30.1%

Finance Costs 25.0 4.1% 34.3 7.5% -27.0%

Depreciation & Amortization 36.9 6.1% 35.9 7.8% 2.8%

PAT* 42.3 6.9% 9.8 2.1% 330.2%

EPS for the period 1.70 0.71

#Other income includes interest income and miscellaneous income

* PAT is arrived after excluding exceptional items

15

��Hospital PerformancesHospital Performances

15

Hospital wise Revenue & EBITDAHospital wise Revenue & EBITDA

16

54.5

69.9

41.542.7

22.8

29.7

17.9

25.7

13.8

18.7

8.1

17.3

9

16.7

11.1

13.1

5.8 7.3

0

10

20

30

40

50

60

70

80

Delhi Mohali Noida Vasant Kunj Faridabad Malar Jaipur Amritsar La Femme

Q3 FY09 Q3 FY10

18

%

19

%

3%

28

%

22

%

30%

44%

15

% 25

%

13

% 27

%

14

% 15

%

13

% 18

%

85%

-6% 2

0%

30

%

28

%

7% 24

%

Rs. In Cr.

28%

35%

112%

18%

27%

Cardiac, 43%

Ortho, 8%

Neuro, 5%

Onco, 2%

Renal, 4% Gastro, 2%

MSH, 17%

OPD, 10%

Pulmo, 2%

Gynae, 3%

Others, 4%

Other, 19%

Specialty Mix Specialty Mix –– 9MFY109MFY10

17

Focus on key specialties Cardiac, Neuro, Ortho, Renal & Onco to continue…

Greenfield Hospitals : PlannedGreenfield Hospitals : Planned

No. Location No. of Beds Area & Land Ownership Expected date of

commencement

1. Shalimar Bagh, NCR 350 7 Acres. Owned Q4’ 10

2. Kolkata, West Bengal 414Owned

294,931 Sq ftQ3’ 11

3. Gurgaon, NCR 450 11 Acres, Owned Q4’ 11

4. Peenya, Bengaluru 120B. Lease

~70,000 Sq ftQ4’ 11

5. Ludhiana – 2, Punjab 100 1,00,000 sq ft. B. Lease Q4’ 12

6. Ludhiana – 1, Punjab 200 1,55,000 sq. ft., B. Lease Q1’ 13

7. Ahmedabad, Gujarat 200 1,55,000 sq. ft., B. Lease Q2’ 13

Total 1,834

18

Thank You…Thank You…

19